why choose us

First received: January 30, 2023

Clinical Trial: CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: GVHD,Acute

Study Type: OBSERVATIONAL


Official Title: CXC-chemokine Ligand 9 (CXCL9) and Endothelial Activation and Stress Index (EASIX) for Prediction of Acute Graft Versus Host Disease

Brief Summary: The prediction of severe acute GVHD before it occurs is of high importance for ensuing clinical decisions and overall success of allogeneic SCT.The key immunologic signatures associated with clinical outcomes after different graft versus host disease prophylaxis methods or peripheral blood stem cell transplant are largely unknown.

Read more